VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
ETON
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
HomeStocksETONInstitutional Holders

ETON logoEton Pharmaceuticals, Inc. (ETON) Institutional Ownership

Q2 2026 13F Data|Updated 2026-11-18

✨

Institutional ownership increased this quarter (+5.60 pp), though top 10 holders maintain a highly concentrated 61.6% of institutional value.

Institutional Ownership
Can exceed 100% due to securities lending, short interest, and reporting timing differences.
73.6%$717M total value · ▲ +5.60 pp vs prior quarter
Smart Money Score
Based on ownership concentration, fund quality, buying/selling activity, ownership indicators, and institutional trend.
75 / 100Bullish
Institutions & Flow163 holders+47 net flow (+52 / -5)

AI Insights & Key Takeaways

  • Positive Institutional Flow (+47)
  • Jane Street Group, Llc maintains a significant position
  • Top 10 holders control 61.6% of institutional value
  • No Insider Signal

Top Institutional Holders of ETON

Ranked by reported Q2 2026 13F market value

Top 10 Holders
61.6%
Top 25 Holders
81.1%

Share of total reported institutional value in ETON held by the largest 10 / 25 filers.

#InstitutionShares HeldMarket ValueQoQ ChangeOwnership %% of Fund
1Opaleye Management Inc.2.9M$103.5M0.0%10.441%9.38%
2EcoR1 Capital, LLC2.2M$78.6M0.0%7.929%3.82%
3BlackRock, Inc.1.9M$68.6M+10.4%6.921%0.00%

Quarterly Institutional Activity

Filings activity in ETON during Q2 2026, grouped by how each filer changed its position.

OverviewNew Buyers52Added To90Trimmed18Exited5
  • D. E. Shaw & Co., Inc.$6.8M
  • Prospect Capital Advisors, LLC$5.7M
  • WASATCH ADVISORS LP

ETON Institutional Ownership by Quarter

8 quarters of 13F filings · Δ columns show change vs prior quarter

QuarterInst. HoldersΔ HoldersOwnership %Δ OwnershipTotal 13F ValueΔ Value
Q2 2026163+41%73.59%+5.60 pp$717M+69%
Q1 2026116+12%67.99%+6.85 pp$423M+61%
Q4 2025104+2.0%61.14%7.31 pp$263M30%
Q3 2025102+20%68.45%+3.91 pp$376M+66%
Q2 202585+0.0%64.54%+9.97 pp$227M+30%
Q1 202585+20%

How ETON Compares to Peers

Institutional ownership and quarterly buying activity across the largest Rare Disease Biotech peers.

TickerCompanyMarket CapInst. OwnershipHoldersNet Buyers − Sellers
IRLAIRulya Therapeutics Inc.$39M23.9%42-29

ETON — Frequently Asked Questions

Quick answers to the most common questions about buying ETON stock.

What percentage of ETON is owned by institutions?

Based on Q2 2026 13F filings, institutional ownership of Eton Pharmaceuticals, Inc. stands at 73.6%, held across 163 reporting institutions.

Who is the largest institutional holder of ETON?

Opaleye Management Inc. is the largest reported institutional holder of ETON, with approximately 2,860,000 shares worth $0.10B as of Q2 2026.

Is ETON a hedge fund favorite?

Yes — 1 widely-followed marquee investor appear among the top 25 institutional holders of ETON, including JANE STREET GROUP, LLC.

What is ETON's Smart Money Score?

Our composite Smart Money Score for ETON is 75 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.

How many institutions bought ETON this quarter?
4
Nantahala Capital Management, LLC
1.2M
$42.6M
0.0%
4.293%
0.71%
5VANGUARD CAPITAL MANAGEMENT LLC977K$35.4M-1.8%3.565%0.00%
6MORGAN STANLEY768K$27.8M+60.7%2.804%0.00%
7STATE STREET CORP702K$25.4M+32.4%2.562%0.00%
8GEODE CAPITAL MANAGEMENT, LLC652K$23.6M+12.9%2.381%0.00%
9OBERWEIS ASSET MANAGEMENT INC/502K$18.2M+14.2%1.831%0.38%
10National Philanthropic Trust492K$17.8M0.0%1.796%0.26%
11Westside Investment Management, Inc.431K$15.6M-7.9%1.574%2.05%
12Pillsbury Lake Capital LLC387K$14.0M+6.1%1.413%3.83%
13Nuveen, LLC376K$13.6M+548.3%1.372%0.00%
14BNP PARIBAS FINANCIAL MARKETS322K$11.7M+6.7%1.177%0.00%
15Woodline Partners LP311K$11.3M+82.1%1.135%0.03%
16NORTHERN TRUST CORP256K$9.3M+7.6%0.934%0.00%
17MARSHALL WACE, LLP249K$9.0M+201.2%0.910%0.01%
18JANE STREET GROUP, LLC220K$8.0M+64.7%0.803%0.00%
19Panoramic Capital, LLC208K$7.5M+12.5%0.760%3.24%
20VANGUARD PORTFOLIO MANAGEMENT LLC195K$7.0M+28.2%0.710%0.00%
21JPMORGAN CHASE & CO192K$7.0M+12.8%0.700%0.00%
22D. E. Shaw & Co., Inc.188K$6.8M—0.688%0.00%
23Lumbard & Kellner, LLC176K$6.4M0.0%0.642%1.93%
24CANNELL CAPITAL LLC171K$6.2M-50.1%0.623%4.14%
25NORGES BANK170K$6.1M—0.619%0.00%

denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in ETON — a direct measure of their conviction.

$3.4M
  • Squarepoint Ops LLC$2.2M
  • Point72 Asset Management, L.P.$1.6M
  • DIMENSIONAL FUND ADVISORS LP$1.5M
  • HSBC HOLDINGS PLC$1.5M
  • Jefferies Financial Group Inc.$1.2M
  • Y-Intercept (Hong Kong) Ltd$1.2M
  • Riggs Asset Managment Co. Inc.$1.2M
  • Sigma Planning Corp$1.1M
  • STRS OHIO$854K
  • 54.57%
    +2.85 pp
    $175M
    +1.6%
    Q4 202471+48%51.72%+12.74 pp$172M+201%
    Q3 202448—38.98%—$57M—

    Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.

    52 institutions opened new positions in ETON during Q2 2026, while 5 fully exited. 90 added to existing positions and 18 trimmed.

    How is institutional ownership of ETON changing?

    ETON institutional ownership rose by 5.60 percentage points quarter-over-quarter, with a net change of +47 holders.

    How concentrated is ETON ownership among the top holders?

    The top 10 institutions account for 61.6% of all reported 13F value in ETON, and the top 25 account for 81.1%.

    How does ETON compare to Rare Disease Biotech on institutional ownership?

    Across the largest Rare Disease Biotech peers, institutional ownership levels are: IRLA (23.9%). See the peer comparison table on this page for net buyer activity by company.

    Where does this ETON institutional ownership data come from?

    All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.

    ETONEton Pharmaceuticals, Inc.
    $61.99$1.7B
    Overview & Tools
    OverviewChart Terminal ↗Visualize
    Valuation & Forecasts
    Valuation ModelsEstimatesDCF Model
    Price & Analyst Data
    Analyst TargetsPrice History
    Financial Statements
    Income StatementBalance SheetCash FlowRatios & Margins
    Performance
    P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
    Discovery & Screens
    Live BreakoutsStock ScreenerOwnership